SMAD2 and chronic kidney disease: The biological activity of IS during chronic kidney disease is correlated with the severity of numerous pathological conditions, including the induction of oxidative stress, inflammation, and activation of signalling pathways related to NF-κB, p53, STAT3, TGF-β and Smad2/320–22.